CA2950443A1 - Osteoclast inhibitors for pain - Google Patents

Osteoclast inhibitors for pain Download PDF

Info

Publication number
CA2950443A1
CA2950443A1 CA2950443A CA2950443A CA2950443A1 CA 2950443 A1 CA2950443 A1 CA 2950443A1 CA 2950443 A CA2950443 A CA 2950443A CA 2950443 A CA2950443 A CA 2950443A CA 2950443 A1 CA2950443 A1 CA 2950443A1
Authority
CA
Canada
Prior art keywords
mg
method
zoledronic acid
kg
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2950443A
Other languages
French (fr)
Inventor
Herriot TABUTEAU
Eric K.M. DINKLA
Graeme Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Antecip Bioventures II LLC
Original Assignee
Antecip Bioventures II LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201414228241A priority Critical
Priority to US14/228,241 priority
Priority to US14/288,713 priority patent/US8901162B1/en
Priority to US14/288,716 priority
Priority to US14/288,720 priority
Priority to US14/288,713 priority
Priority to US14/288,720 priority patent/US8865757B1/en
Priority to US14/288,716 priority patent/US8835650B1/en
Priority to US201462012112P priority
Priority to US62/012,112 priority
Priority to US14/310,811 priority patent/US8822436B1/en
Priority to US14/310,811 priority
Priority to US14/336,642 priority patent/US20140329773A1/en
Priority to US14/336,642 priority
Priority to US14/446,184 priority
Priority to US14/446,184 priority patent/US9006279B1/en
Priority to USPCT/US2014/050427 priority
Priority to PCT/US2014/050427 priority patent/WO2015060924A1/en
Priority to US14/457,659 priority patent/US20140349974A1/en
Priority to US14/457,659 priority
Priority to US14/481,097 priority
Priority to US14/481,097 priority patent/US8962599B1/en
Priority to US62/053,619 priority
Priority to US201462053619P priority
Priority to US14/495,732 priority patent/US9127069B1/en
Priority to US14/495,732 priority
Priority to US14/530,556 priority patent/US20150051175A1/en
Priority to US14/530,556 priority
Priority to US14/536,526 priority patent/US20150057250A1/en
Priority to US14/536,526 priority
Priority to US14/538,709 priority
Priority to US14/538,709 priority patent/US9290575B2/en
Priority to US14/540,333 priority
Priority to US14/540,333 priority patent/US9216168B1/en
Priority to US14/604,524 priority
Priority to US14/604,524 priority patent/US9211257B2/en
Priority to US14/605,822 priority patent/US9216153B2/en
Priority to US14/605,822 priority
Priority to US14/607,947 priority
Priority to US14/607,985 priority patent/US9289385B2/en
Priority to US14/607,947 priority patent/US9289384B2/en
Priority to US14/607,985 priority
Priority to US14/608,855 priority patent/US9079927B1/en
Priority to US14/608,855 priority
Priority to US14/625,457 priority patent/US9427403B2/en
Priority to US14/625,457 priority
Priority to US62/127,214 priority
Priority to US201562127214P priority
Priority to US14/635,857 priority
Priority to US14/635,857 priority patent/US9283239B2/en
Priority to US14/639,013 priority
Priority to US14/639,013 priority patent/US9289441B2/en
Priority to US14/686,551 priority
Priority to US14/686,551 priority patent/US9408860B2/en
Priority to PCT/US2015/032739 priority patent/WO2015184003A1/en
Application filed by Antecip Bioventures II LLC filed Critical Antecip Bioventures II LLC
Publication of CA2950443A1 publication Critical patent/CA2950443A1/en
Application status is Pending legal-status Critical

Links